ARCHIVES

In Brief: NCAB To Hear Report On Controversial Special Virus Cancer Program March 19; Centers, Bladder Project Also On Agenda

This article is from The Cancer Letter archive.

Vol. 01 No. 05 | March 8, 1974

Download PDF Visit The Full Archive

Related Articles

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977

Public Interest Representatives Says Clearinghouse Delayed TRIS Action; Brown Refutes Charge

March 10, 1978

NCI-Approved Clinical Trials

December 30, 2005

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

October issue of Business & Regulatory Report included.

November 5, 2004

Final Issues Of 1982

December 10, 1982